Characteristics | Study groups | |||
---|---|---|---|---|
 | SM | UM | p Value | HC |
Number of subjects | 50 | 39 | Â | 25 |
Gender female/male | 20/30 | 23/16 | NS× | 14/11 |
+Age (months) | 30 (9–86) | 35 (9–83.5) | NS‡ | 31.5 (10–77) |
+Onset of signs and symptoms in days before admission | 3 (0–30) | 3 (0–21) | NS |  |
+sMODS | 18 (13–26) | 13 (10–20) | < 0.001 |  |
+Parasite count (μL-1) | 69,225 (155–900,000) | 23,910 (425–180,000) | < 0.05 |  |
WBC × 103 (μL-1) | 10.5 ± 5.9 | 7.7 ± 3.1 | < 0.05 | 8.9 ± 2.6 |
RBC × 106 (μl-1) | 2.9 ± 1.1 | 3.8 ± 0.6 | < 0.001 | 4.7 ± 0.5 |
Mean Hb (g/dL) | 6.8 ± 2.5 | 8.7 ± 1.5 | < 0.001 | 10.7 ± 1.0 |
Platelets × 103 (μl-1) | 159 ± 109 | 220 ± 132 | < 0.005 | 381 ± 98 |
ET-1 on admission (fmol/ml) | 0.76 ± 0.48 | 1.11 ± 0.98 | <0.001‡ | 0.49 ± 0.31 |
ET-1 after 24 hours (fmol/ml) | 0.72 ± 0.49 | 0.95 ± 0.71 | NS‡ |  |
CNP on admission (pmol/l) | 11.05 ± 6.58 | 11.49 ± 4.55 | <0.05‡ | 14.29 ± 6.4 |
CNP after 24 hours (pmol/l) | 11.5 ± 6.83 | 9.92 ± 3.64 | NS‡ |  |